• This record comes from PubMed

Rhodamine bound maghemite as a long-term dual imaging nanoprobe of adipose tissue-derived mesenchymal stromal cells

. 2017 Jul ; 46 (5) : 433-444. [epub] 20161126

Language English Country Germany Media print-electronic

Document type Journal Article

Links

PubMed 27889810
DOI 10.1007/s00249-016-1187-1
PII: 10.1007/s00249-016-1187-1
Knihovny.cz E-resources

In the last few years, magnetically labeled cells have been intensively explored, and non-invasive cell tracking and magnetic manipulation methods have been tested in preclinical studies focused on cell transplantation. For clinical applications, it is desirable to know the intracellular pathway of nanoparticles, which can predict their biocompatibility with cells and the long-term imaging properties of labeled cells. Here, we quantified labeling efficiency, localization, and fluorescence properties of Rhodamine derivatized superparamagnetic maghemite nanoparticles (SAMN-R) in mesenchymal stromal cells (MSC). We investigated the stability of SAMN-R in the intracellular space during a long culture (20 days). Analyses were based on advanced confocal microscopy accompanied by atomic absorption spectroscopy (AAS) and magnetic resonance imaging. SAMN-R displayed excellent cellular uptake (24 h of labeling), and no toxicity of SAMN-R labeling was found. 83% of SAMN-R nanoparticles were localized in lysosomes, only 4.8% were found in mitochondria, and no particles were localized in the nucleus. On the basis of the MSC fluorescence measurement every 6 days, we also quantified the continual decrease of SAMN-R fluorescence in the average single MSC during 18 days. An additional set of analyses showed that the intracellular SAMN-R signal decrease was minimally caused by fluorophore degradation or nanoparticles extraction from the cells, main reason is a cell division. The fluorescence of SAMN-R nanoparticles within the cells was detectable minimally for 20 days. These observations indicate that SAMN-R nanoparticles have a potential for application in transplantation medicine.

See more in PubMed

Pharm Res. 1997 Nov;14(11):1568-73 PubMed

Cytotherapy. 2013 Mar;15(3):307-22 PubMed

Phys Chem Chem Phys. 2013 Feb 21;15(7):2282-90 PubMed

Mol Imaging Biol. 2011 Jun;13(3):443-451 PubMed

Spectrochim Acta A Mol Biomol Spectrosc. 2014;121:147-51 PubMed

NMR Biomed. 2004 Nov;17 (7):513-7 PubMed

Angew Chem Int Ed Engl. 2011 Feb 7;50(6):1242-58 PubMed

Biomaterials. 2012 Feb;33(5):1477-88 PubMed

J Orthop Res. 2012 Sep;30(9):1499-506 PubMed

Pharmacol Res. 2010 Aug;62(2):126-43 PubMed

Int J Nanomedicine. 2015 Mar 02;10:1679-90 PubMed

Nat Biotechnol. 2000 Apr;18(4):410-4 PubMed

J Biosci Bioeng. 2002;94(6):606-13 PubMed

Biomaterials. 2013 Feb;34(7):1772-80 PubMed

Int J Pharm. 2011 Jan 17;403(1-2):139-61 PubMed

Small. 2010 Jan;6(1):12-21 PubMed

Br J Radiol. 2015 Oct;88(1054):20150375 PubMed

Micron. 2014 Dec;67:149-154 PubMed

Radiology. 2003 Sep;228(3):760-7 PubMed

Cytotherapy. 2009;11(1):43-51 PubMed

Acta Biomater. 2012 Jul;8(6):2068-76 PubMed

Adv Healthc Mater. 2014 Feb;3(2):176-81 PubMed

Int J Nanomedicine. 2014 Nov 20;9:5355-72 PubMed

Biochem Biophys Res Commun. 2008 May 16;369(4):1076-81 PubMed

Magn Reson Med. 2003 Jun;49(6):1006-13 PubMed

Int J Nanomedicine. 2012;7:2249-59 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...